Search Results - "Ojalvo, Ariana G"
-
1
Expression of cell proliferation cycle negative regulators in fibroblasts of an ischemic diabetic foot ulcer. A clinical case report
Published in International wound journal (01-04-2013)“…Wound chronification and opportunistic infections stand as major factors leading to lower extremities amputations in diabetes. The molecular mechanisms…”
Get full text
Journal Article -
2
A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic
Published in Immunology letters (01-12-1999)“…Streptokinase (SK) is the most widely used compound for the treatment of myocardial infarction and the least expensive thrombolytic agent, but a drawback to…”
Get full text
Journal Article -
3
Prevalence of Circulating Antibodies against a Streptokinase C-Terminal Peptide in Normal Blood Donors
Published in Biochemical and biophysical research communications (24-09-1999)“…Streptokinase (SK) is a streptococcal protein widely used as a thrombolytic agent. Anti-SK antibodies (Abs) are found in most individuals due to common…”
Get full text
Journal Article -
4
Mapping of the Antigenic Regions of Streptokinase in Humans after Streptokinase Therapy
Published in Biochemical and biophysical research communications (27-05-1999)“…Streptokinase (SK) is efficaciously used as a thrombolytic drug for the treatment of myocardial infarction. Being a bacterial protein, SK is immunogenic in…”
Get full text
Journal Article -
5
A Mutant Streptokinase Lacking the C-Terminal 42 Amino Acids Is Less Reactive with Preexisting Antibodies in Patient Sera
Published in Biochemical and biophysical research communications (09-12-1999)“…Streptokinase (SK) is an efficacious thrombolytic drug for the treatment of myocardial infarction. Because of its immunogenicity, patients receiving SK therapy…”
Get full text
Journal Article -
6
Therapeutic angiogenesis following intramuscular gene transfer of vascular endothelial growth factor 121 in a dog model of hindlimb ischemia
Published in Electronic Journal of Biotechnology (25-05-2004)“…Vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen, has been shown to promote therapeutic angiogenesis in animal models of…”
Get full text
Journal Article -
7
Intramyocardial gene transfer of vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
Published in Electronic Journal of Biotechnology (02-02-2005)“…Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is angiogenic in vitro and in vivo. Several studies report on gene…”
Get full text
Journal Article -
8
Therapeutic angiogenesis following intramuscular gene transfer of vascular endothelialgrowth factor 121 in a dog model of hindlimb ischemia
Published in Electronic Journal of Biotechnology (01-12-2003)“…Abstract Reprint (BIP) Reprint (PDF) Abstract Article References Vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen, has been…”
Get full text
Journal Article -
9
Intramyocardial gene transfer of vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
Published in Electronic Journal of Biotechnology (01-12-2004)“…Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is angiogenic in vitro and in vivo. Several studies report on gene…”
Get full text
Journal Article -
10
-
11
-
12